Top 5 Diversified Bank Stocks To Buy Right Now

Top 5 Diversified Bank Stocks To Buy Right Now: Hansen Medical Inc.(HNSN)

Hansen Medical, Inc. develops, manufactures, and sells medical robotics designed for positioning, manipulation, and control of catheters and catheter-based technologies. The company?s products comprise the Sensei Robotic Catheter System and its related Artisan and Lynx catheters. It offers Sensei Robotic Catheter systems and Artisan catheters for manipulation, positioning, and control of mapping catheters during electrophysiology procedures. The company also provides robotic platforms consisting of the Magellan Robotic System and the NorthStar Robotic Catheter for the treatment of vascular disease. In addition, it offers CoHesion 3D Visualization Module, a software interface that provide physicians with 3D visualization to augment their ability to move a catheter throughout the heart, as well as control the placement of the catheter in specific locations. The company sells its products through direct sales force in the United States; and through direct sales force and dis tributors primarily in the European Union and internationally. It has a joint development agreement and co-marketing agreement with St. Jude Medical, Inc. for the development of CoHesion 3D Visualization Module; and a collaboration agreement with Philips Medical Systems Nederland B.V. to co-develop integrated products for use in the diagnosing and treatment of arrhythmias. The company was founded in 2002 and is headquartered in Mountain View, California.

Advisors' Opinion:

• [By Roberto Pedone]

  One health care player that insiders are active in here is Hansen Medical (HNSN), which develops, manufactures and markets new generation of medical robotics for accurate positioning, manipulation and stable control of catheters and catheter-based technologies. Insiders are buying this stock into relative weakness, since shares are off by 19.2% so far in 2013.

  Hansen Medical has a market cap of $113 million and an ente! rprise value of $118 million. This stock trades at a premium valuation, with a price-to-sales of 7.13. Its estimated growth rate for this year is -3%, and for next year it's pegged at 36.2%. This is not a cash-rich company, since the total cash position on its balance sheet is $21.08 million and its total debt is $29.57 million.

  A beneficial owner just bought 8.1 million shares, or about $9.96 million worth of stock, at $1.23 per share.

  From a technical perspective, HNSN is currently trending above its 50-day and just below is 200-day moving average, which is neutral trendwise. This stock recently spiked up sharply from its low of $1.14 to its recent high of $1.96 a share with big upside volume. Since that move, shares of HNSN have pulled back and started to consolidation between $1.77 and $1.60 a share. This stock is now starting to bounce higher and move within range of triggering a near-term breakout trade.

  If you're bullish on HNSN, then look for long-biased trades as long as this stock is trending some key near-term support levels at $1.60 to its 50-day at $1.51, and then once it breaks out above some near-term overhead resistance levels at $1.77 to $1.96 a share high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average volume of 530,653 shares. If that breakout hits soon, then HNSN will set up to re-test or possibly take out its next major overhead resistance levels at $2.15 to $2.23 a share. Any high-volume move above those levels will then gi

• [By John Udovich]

  Small cap robotic stock Adept Technology (NASDAQ: ADEP) has put in a very good performance this month verses its immediate peeriRobot Corporation (NASDAQ: IRBT) as well as against medical robotic stocks like MAKO Surgical (NASDAQ: MAKO), Accuray Incorporated (NASDAQ: ARAY) and Hansen Medical, Inc (NASDAQ: HNSN). I should also mention that we have recently added Adept Technology to our SmallCap Network Elite Opportunity (SCN EO)! portfoli! o (we are up 9% since last week) because we feel robotics is an improving sector as companies aim to reduce overhead and improve efficiencies through machine to machine (M2M) automation.

• [By Rich Smith]

  While billed as a rival to America's Intuitive Surgical (NASDAQ: ISRG  ) , Mazor actually bears closer resemblance to tiny Hansen Medical (NASDAQ: HNSN  ) . Lacking profits despite raking in nearly $15 million in revenues last year, Mazor doesn't generate positive free cash flow like Intuitive does. Instead, it burns it like Hansen does (albeit more slowly). Last year, negative free cash flows amounted to $2.1 million, which suggests that Wallachbeth's endorsement may be a bit premature.

• [By John Udovich]

  Yesterday, small cap medical robotics stock MAKO Surgical Corp (NASDAQ: MAKO) soared 82.19% after it was announced that Stryker Corporation (NYSE: SYK) would acquire it meaning it might be time to take a closer look at large cap medical robotics leader Intuitive Surgical, Inc (NASDAQ: ISRG) along with small caps Accuray Incorporated (NASDAQ: ARAY) and Hansen Medical, Inc (NASDAQ: HNSN). MAKO Surgical Corpmarkets both its RIO Robotic Arm Interactive Orthopedic System and proprietary RESTORIS family of implants to surgeons for a procedure called MAKOplastythat provides a less invasive method for knee resurfacing and a new procedure for Total Hip Arthroplasty.Stryker Corporation, whose medical technologies include reconstructive, medical and surgical, and neurotechnology and spine products, agreed to pay $1.65 billion or $30 a share for a massive 86%premium for MAKO Surgical Corp. Thats sounds great for investors unless you are an investor who go in the stock ba ck in 2011 and early 2012 when shares hit as high as the$43 level.

source from Top Penny Stocks For 2015:http://www.seekpennystocks.com/top-5-diversified-bank-stocks-to-buy-right-now-3.html